168 related articles for article (PubMed ID: 35527321)
1. Cancerization of ducts in hilar cholangiocarcinoma.
Lee JW; Zhang Y; Yoshizawa T; Argani P; Wood LD; Oshima K
Virchows Arch; 2022 Aug; 481(2):1-10. PubMed ID: 35527321
[TBL] [Abstract][Full Text] [Related]
2. Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression.
Hutchings D; Waters KM; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Wood LD; Hruban RH
Am J Surg Pathol; 2018 Nov; 42(11):1556-1561. PubMed ID: 30212393
[TBL] [Abstract][Full Text] [Related]
3. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
[TBL] [Abstract][Full Text] [Related]
4. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
5. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
6. Histological characteristics of biliary intraepithelial neoplasia-3 and intraepithelial spread of cholangiocarcinoma.
Sato Y; Harada K; Sasaki M; Nakanuma Y
Virchows Arch; 2013 Apr; 462(4):421-7. PubMed ID: 23446751
[TBL] [Abstract][Full Text] [Related]
7. Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas.
Akita M; Fujikura K; Ajiki T; Fukumoto T; Otani K; Azuma T; Itoh T; Ku Y; Zen Y
Mod Pathol; 2017 Jul; 30(7):986-997. PubMed ID: 28338651
[TBL] [Abstract][Full Text] [Related]
8. [Gallbladder and bile duct carcinoma. Biology and pathology].
Tannapfel A; Wittekind C
Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
10. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
Nakanuma Y; Uchida T; Sato Y; Uesaka K
Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
[TBL] [Abstract][Full Text] [Related]
11. Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.
Zhang CW; Liu J; Hong DF; Wang ZF; Hu ZM; Huang DS; Shang MJ; Yao WF
Surg Endosc; 2018 Mar; 32(3):1581-1582. PubMed ID: 28779241
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
13. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
14. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
15. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.
Sasaki R; Takeda Y; Funato O; Nitta H; Kawamura H; Uesugi N; Sugai T; Wakabayashi G; Ohkohchi N
World J Surg; 2007 Sep; 31(9):1788-1796. PubMed ID: 17647056
[TBL] [Abstract][Full Text] [Related]
16. ASO Author Reflections: Importance of Preoperative Diagnosis of Lymph Node Metastasis in Perihilar Cholangiocarcinoma.
Hosokawa I; Togasaki K; Ohtsuka M
Ann Surg Oncol; 2022 Sep; 29(9):5511-5512. PubMed ID: 35622178
[No Abstract] [Full Text] [Related]
17. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
Wang X; Zhang J; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
[TBL] [Abstract][Full Text] [Related]
18. Is intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma of limited value?
Ma WJ; Shrestha A; Li FY
Cancer Med; 2016 Oct; 5(10):2848-2849. PubMed ID: 27686472
[TBL] [Abstract][Full Text] [Related]
19. Bile duct dysplasia and associated invasive carcinoma: clinicopathological features, diagnosis, and practical challenges.
Liu Y; Yeh MM
Hum Pathol; 2023 Feb; 132():158-168. PubMed ID: 35714833
[TBL] [Abstract][Full Text] [Related]
20. Hilar cholangiocarcinoma: pathology and tumor biology.
Kuang D; Wang GP
Front Med China; 2010 Dec; 4(4):371-7. PubMed ID: 21110142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
